OBESITY PROFILE AS A RISK FACTOR IN RENAL CELL CARCINOMA PATIENTS: A LITERATURE REVIEW
##plugins.themes.bootstrap3.article.main##
##plugins.themes.bootstrap3.article.sidebar##
Abstract
Objective: This study aims to determine the profile of obesity as a risk factor for developing RCC. Material & Methods: This study is a library research study with journals, articles, and opinions of related experts taken from Google Scholar and Pubmed which was uploaded in 2019-2023. Results: 7 articles met the inclusion, exclusion and topic relevance criteria. Several journals stated that obesity is a strong risk factor for the development of renal cell carcinoma (RCC), although opposite results were found in one study regarding obesity and the prognostic outcome of RCC patients. Discussion: The mechanism of obesity in increasing the risk of RCC is a complex process, which involves the process of insulin resistance, inflammation by pro-inflammatory cytokines, angiogenesis, and proliferative effects as a result of the role of insulin as one of the most important anabolic hormones capable of stimulating cell proliferation, and is exacerbated by imbalanced cell anti-apoptotic mechanisms. Conclusion: No relationship was found between the lipid profile and the incidence of RCC. Little research has been done on lipid profiles for RCC, considering that the largest RCC subtype, ccRCC, is characterized by the accumulation of lipids and glycogen, which has implications for changes in fatty acid and glucose metabolism in its etiology. Further studies are needed to examine the effect of lipid profiles on the risk of renal cell carcinoma. Keywords: Carcinogenesis, obesity profile, renal cell carcinoma.
##plugins.themes.bootstrap3.article.details##
Carcinogenesis, Obesity Profile, Renal cell Carcinoma
Al-Bayati O, Hasan A, Pruthi D, Kaushik D, Liss MA. Systematic review of modifiable risk factors for kidney cancer. Urol Oncol Semin Orig Investig. Elsevier Inc.; 2019;37(6):359–71.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.
Lee SJ, Shin SW. Mechanisms, Pathophysiology, and Management of Obesity. The New England journal of medicine. United States; 2017. p. 1491–2.
Gluba-Brzózka A, Rysz J, Ławiński J, Franczyk B. Renal Cell Cancer and Obesity. Int J Mol Sci. 2022;23(6).
Callahan CL, Hofmann JN, Corley DA, Zhao WK, Shuch B, Chow WH, et al. Obesity and renal cell carcinoma risk by histologic subtype: A nested case-control study and meta-analysis. Cancer Epidemiol. Elsevier; 2018;56(July):31–7.
Steele CB, Thomas CC, Henley ; S Jane, Massetti GM, Galuska DA, Agurs-Collins T, et al. Morbidity and Mortality Weekly Report Vital Signs: Trends in Incidence of Cancers Associated with Overweight and Obesity — United States, 2005–2014. Centers Dis Control Prev. 2017;6(66):1052–8.
Li M, Bu R. Biological Support to Obesity Paradox in Renal Cell Carcinoma: A Review. Urol Int. 2020;104(11–12):837–48.
Turco F, Tucci M, Di Stefano RF, Samuelly A, Bungaro M, Audisio M, et al. Renal cell carcinoma (RCC): Fatter is better? A review on the role of obesity in RCC. Endocr Relat Cancer. 2021;28(7):R207–16.
Kim SH, Park B, Hwang EC, Hong S-H, Jeong CW, Kwak C, et al. Retrospective Multicenter Long-Term Follow-up Analysis of Prognostic Risk Factors for Recurrence-Free, Metastasis-Free, Cancer-Specific, and Overall Survival After Curative Nephrectomy in Non-metastatic Renal Cell Carcinoma. Front Oncol. Switzerland; 2019;9:859.
Landberg A, Fält A, Montgomery S, Sundqvist P, Fall K. Overweight and obesity during adolescence increases the risk of renal cell carcinoma. Int J cancer. United States; 2019 Sep;145(5):1232–7.
Johansson M, Carreras-Torres R, Scelo G, Purdue MP, Mariosa D, Muller DC, et al. The influence of obesity-related factors in the etiology of renal cell carcinoma-A mendelian randomization study. PLoS Med. 2019;16(1):1–16.
Johansson M, Fanidi A, Muller DC, Bassett JK, Midttun Ø, Vollset SE, et al. Circulating biomarkers of one-carbon metabolism in relation to renal cell carcinoma incidence and survival. J Natl Cancer Inst. United States; 2014 Dec;106(12).
Hao P, Kang B, Li Y, Hao W, Ma F. UBE2T promotes proliferation and regulates PI3K/Akt signaling in renal cell carcinoma. Mol Med Rep. Greece; 2019 Aug;20(2):1212–20.
Lee HY, Han K, Woo IS. Association of Metabolic Syndrome Components and Nutritional Status with Kidney Cancer in Young Adult Population : A Nationwide Population-Based Cohort Study in Korea. 2023;
Gelfond J, Al-Bayati O, Kabra A, Iffrig K, Kaushik D, Liss MA. Modifiable risk factors to reduce renal cell carcinoma incidence: Insight from the PLCO trial. Urol Oncol. United States; 2018 Jul;36(7):340.e1-340.e6.